Company · CIK 0000920148 · SIC 8071 — Services-Medical Laboratories · NYSE
LABCORP HOLDINGS INC. · LH
Insider activity reported against this company. All insider holders · Files at: SQNM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2018 FMForm 4 → | Feb 9, 3:47 pm EST | Jean-Luc BelingardDirector | 1,390 | $169.66 | $21,547 | 33,079 | — | plan? |
| Feb 7, 2018 MForm 4 → | Feb 9, 3:44 pm EST | Kerrii B AndersonDirector | 1,263 | — | — | 18,095 | — | plan? |
| Oct 30, 2017 SForm 4 → | Nov 1, 10:31 am EDT | Dwight Gary GillilandDirector | 971 | $153.52 | $149,068 | 3,501 | −21.7% | plan? |
| Sep 8, 2017 GForm 5 → | Jan 23, 2018, 9:06 am EST | David P KingPresident & CEO, Director | 104,770 | — | — | 0 | — | plan? |
| Sep 6, 2017 SForm 4 → | Sep 7, 3:35 pm EDT | David P KingPresident & CEO, Director | 44,687 | $156.86 | $7,009,784 | 214,066 | −17.3% | plan? |
| Sep 6, 2017 MForm 4 → | Sep 7, 3:35 pm EDT | David P KingPresident & CEO, Director | 44,687 | $90.74 | $4,054,898 | 258,753 | — | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 9:18 am EDT | David P KingPresident & CEO, Director | 132,713 | $157.06 | $20,843,373 | 214,066 | −38.3% | plan? |
| Sep 1, 2017 FMForm 4 → | Oct 23, 4:10 pm EDT | M. Huff GaryCEO, LabCorp Diagnostics | 204 | $157.61 | $8,038 | 349 | — | plan? late |
| Aug 25, 2017 SForm 4 → | Aug 29, 2:26 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 31,500 | $155.22 | $4,889,471 | 23,694 | −57.1% | plan? |
| Aug 25, 2017 MForm 4 → | Aug 29, 2:26 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 31,500 | $69.12 | $2,177,239 | 55,194 | — | plan? |
| Aug 11, 2017 SForm 4 → | Aug 15, 3:03 pm EDT | R Sanders WilliamsDirector | 3,100 | $156.88 | $486,338 | 6,973 | −30.8% | plan? |
| Aug 11, 2017 MForm 4 → | Aug 15, 3:03 pm EDT | R Sanders WilliamsDirector | 3,100 | $77.19 | $239,289 | 10,073 | — | plan? |
| Aug 2, 2017 GMForm 4 → | Sep 7, 9:18 am EDT | David P KingPresident & CEO, Director | 134,363 | $90.74 | $12,042,378 | 346,779 | — | plan? late |
| Aug 1, 2017 SForm 4 → | Aug 3, 4:35 pm EDT | Edward T DodsonPrincipal Accounting Officer | 2,871 | $160.13 | $459,739 | 5,031 | −36.3% | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 4:29 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 5,000 | $160.00 | $800,000 | 3,622 | −58.0% | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 4:22 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 5,968 | $159.46 | $951,672 | 18,122 | −24.8% | plan? |
| Jun 16, 2017 FMForm 4 → | Jun 19, 2:48 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 5,976 | $140.77 | $271,123 | 24,090 | — | plan? |
| May 22, 2017 SForm 4 → | May 24, 11:25 am EDT | Lance BerberianSVP, Chief Information Officer | 3,613 | $139.84 | $505,259 | 5,789 | −38.4% | plan? |
| May 9, 2017 SForm 4 → | May 11, 8:17 am EDT | Jean-Luc BelingardDirector | 992 | $142.19 | $141,052 | 31,943 | −3.01% | plan? |
| May 9, 2017 MForm 4 → | May 11, 8:17 am EDT | Jean-Luc BelingardDirector | 992 | $77.58 | $76,959 | 32,935 | — | plan? |
| Mar 29, 2017 AFForm 4 → | Mar 31, 1:50 pm EDT | Lance BerberianSVP, Chief Information Officer | 9,897 | $143.19 | $449,903 | 9,402 | — | plan? |
| Mar 29, 2017 AFForm 4 → | Mar 31, 1:49 pm EDT | Edward T DodsonPrincipal Accounting Officer | 9,605 | $143.19 | $408,092 | 7,754 | — | plan? |
| Mar 29, 2017 AFForm 4 → | Mar 31, 1:48 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 10,982 | $143.19 | $459,926 | 23,694 | — | plan? |
| Mar 29, 2017 AFForm 4 → | Mar 31, 1:47 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 30,263 | $143.19 | $1,396,532 | 21,966 | — | plan? |
| Mar 29, 2017 AFForm 4 → | Mar 31, 1:45 pm EDT | David P KingPresident & CEO, Director | 150,796 | $143.19 | $6,958,461 | 198,359 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 3:17 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 11,871 | $144.24 | $527,053 | 8,602 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 2:52 pm EDT | Lance BerberianSVP, Chief Information Officer | 532 | $144.24 | $19,040 | 5,789 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 2:44 pm EDT | Edward T DodsonPrincipal Accounting Officer | 549 | $144.24 | $21,492 | 3,849 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 2:43 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 616 | $144.24 | $22,069 | 19,136 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 2:41 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 2,401 | $144.24 | $111,642 | 11,209 | — | plan? |
| Mar 11, 2017 FMForm 4 → | Mar 14, 2:39 pm EDT | David P KingPresident & CEO, Director | 8,967 | $144.24 | $416,854 | 144,755 | — | plan? |
| Mar 9, 2017 SForm 4 → | Mar 13, 9:34 am EDT | Glenn A EisenbergChief Financial Officer, EVP | 2,300 | $142.47 | $327,690 | 10,356 | −18.2% | plan? |
| Feb 24, 2017 SForm 4 → | Feb 27, 2:40 pm EST | Robert E Mittelstaedt Jr.Director | 5,300 | $142.69 | $756,258 | 12,908 | −29.1% | plan? |
| Feb 24, 2017 MForm 4 → | Feb 27, 2:40 pm EST | Robert E Mittelstaedt Jr.Director | 5,300 | $75.63 | $400,839 | 18,208 | — | plan? |
| Feb 23, 2017 SForm 4 → | Feb 27, 2:39 pm EST | Kerrii B AndersonDirector | 1,992 | $140.00 | $278,880 | 15,832 | −11.2% | plan? |
| Feb 23, 2017 MForm 4 → | Feb 27, 2:39 pm EST | Kerrii B AndersonDirector | 2,992 | $76.28 | $228,219 | 16,832 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:45 pm EST | Edward T DodsonPrincipal Accounting Officer | 732 | $134.93 | $24,557 | 3,598 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:45 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 840 | $134.93 | $27,796 | 18,826 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:42 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 2,226 | $134.93 | $74,481 | 12,656 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:42 pm EST | Lance BerberianSVP, Chief Information Officer | 1,969 | $134.93 | $65,981 | 5,521 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:42 pm EST | David P KingPresident & CEO, Director | 12,312 | $134.93 | $535,402 | 141,568 | — | plan? |
| Feb 11, 2017 FMForm 4 → | Feb 14, 5:40 pm EST | Lance BerberianSVP, Chief Information Officer | 1,969 | $134.93 | $65,981 | 5,521 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:40 pm EST | Lisa J UthgenanntChief Human Resources Officer | 847 | $133.83 | $32,655 | 4,039 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:31 pm EST | Edward T DodsonPrincipal Accounting Officer | 588 | $133.83 | $18,469 | 3,230 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:28 pm EST | John D RatliffCEO, Covance Drug Development | 8,113 | $133.83 | $269,400 | 4,127 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:26 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 708 | $133.83 | $25,160 | 18,398 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:24 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 6,486 | $133.83 | $215,466 | 11,534 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:23 pm EST | Lance BerberianSVP, Chief Information Officer | 4,667 | $133.83 | $156,715 | 4,530 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 2:21 pm EST | David P KingPresident & CEO, Director | 10,039 | $133.83 | $334,040 | 137,192 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:04 pm EST | Richelle P ParhamDirector | 1,560 | — | — | 1,560 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:01 pm EST | Adam H SchechterDirector | 1,560 | — | — | 6,034 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:58 pm EST | R Sanders WilliamsDirector | 1,560 | — | — | 6,973 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:55 pm EST | Peter M NeupertDirector | 1,560 | — | — | 6,468 | — | plan? |
| Feb 9, 2017 FMForm 4 → | Feb 13, 1:53 pm EST | Jean-Luc BelingardDirector | 1,716 | $133.83 | $20,877 | 31,943 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:51 pm EST | Kerrii B AndersonDirector | 1,560 | — | — | 15,832 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:49 pm EST | Garheng KongDirector | 1,560 | — | — | 4,924 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:46 pm EST | Robert E Mittelstaedt Jr.Director | 1,560 | — | — | 12,908 | — | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:43 pm EST | Dwight Gary GillilandDirector | 1,560 | — | — | 4,472 | — | plan? |
| Nov 14, 2016 GForm 4 → | Nov 16, 3:21 pm EST | David P KingPresident & CEO, Director | 63,202 | — | — | 31,601 | — | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 7:57 am EDT | Lisa J UthgenanntChief Human Resources Officer | 1,177 | $140.00 | $164,780 | 3,660 | −24.3% | plan? |
| Aug 4, 2016 SForm 4 → | Aug 8, 2:58 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 8,000 | $140.10 | $1,120,804 | 8,268 | −49.2% | plan? |
| Aug 4, 2016 SForm 4 → | Aug 8, 2:55 pm EDT | Robert E Mittelstaedt Jr.Director | 992 | $140.15 | $139,027 | 11,348 | −8.04% | plan? |
| Aug 4, 2016 MForm 4 → | Aug 8, 2:55 pm EDT | Robert E Mittelstaedt Jr.Director | 992 | $77.58 | $76,959 | 12,340 | — | plan? |
| Jun 16, 2016 FMForm 4 → | Jun 20, 10:38 am EDT | Glenn A EisenbergChief Financial Officer, EVP | 5,986 | $127.35 | $246,550 | 16,268 | — | plan? |
| Jun 13, 2016 SForm 4 → | Jun 15, 4:03 pm EDT | David P KingPresident & CEO, Director | 196,400 | $128.00 | $25,139,148 | 147,371 | −57.1% | plan? |
| Jun 13, 2016 MForm 4 → | Jun 15, 4:03 pm EDT | David P KingPresident & CEO, Director | 196,400 | $70.15 | $13,777,460 | 219,932 | — | plan? |
| Apr 29, 2016 SForm 4 → | May 13, 4:03 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 3,740 | $125.17 | $468,136 | 4,837 | −43.6% | plan? late |
| Apr 27, 2016 SForm 4 → | Apr 29, 9:01 am EDT | Edward T DodsonPrincipal Accounting Officer | 9,392 | $126.42 | $1,187,337 | 2,717 | −77.6% | plan? |
| Mar 31, 2016 SForm 4 → | Apr 1, 1:12 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 4,219 | $116.85 | $492,990 | 18,066 | −18.9% | plan? |
| Mar 31, 2016 SForm 4 → | Apr 1, 1:11 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 18,132 | $116.81 | $2,118,030 | 23,454 | −43.6% | plan? |
| Mar 30, 2016 AFForm 4 → | Apr 1, 1:22 pm EDT | David P KingPresident & CEO, Director | 149,732 | $117.85 | $5,706,886 | 147,371 | — | plan? |
| Mar 30, 2016 AFForm 4 → | Apr 1, 1:21 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 18,572 | $117.85 | $707,925 | 14,154 | — | plan? |
| Mar 30, 2016 AFForm 4 → | Apr 1, 1:15 pm EDT | Edward T DodsonPrincipal Accounting Officer | 9,034 | $117.85 | $276,830 | 12,109 | — | plan? |
| Mar 30, 2016 AFForm 4 → | Apr 1, 1:12 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 9,151 | $117.85 | $290,618 | 22,285 | — | plan? |
| Mar 30, 2016 AFForm 4 → | Apr 1, 1:11 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 51,342 | $117.85 | $1,956,899 | 41,586 | — | plan? |
| Mar 14, 2016 SForm 4 → | Mar 15, 1:41 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 309 | $115.32 | $35,634 | 18,066 | −1.68% | plan? |
| Mar 14, 2016 SForm 4 → | Mar 15, 1:39 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 1,543 | $115.32 | $177,939 | 23,454 | −6.17% | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:40 pm EDT | Robert E Mittelstaedt Jr.Director | 1,237 | — | — | 11,348 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:39 pm EDT | Peter M NeupertDirector | 1,237 | — | — | 4,908 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:39 pm EDT | Garheng KongDirector | 1,237 | — | — | 3,364 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:38 pm EDT | Adam H SchechterDirector | 1,237 | — | — | 4,474 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:37 pm EDT | Dwight Gary GillilandDirector | 1,237 | — | — | 2,912 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:37 pm EDT | R Sanders WilliamsDirector | 1,237 | — | — | 5,413 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 3:35 pm EDT | Jean-Luc BelingardDirector | 1,361 | $115.49 | $14,321 | 30,539 | — | plan? |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:35 pm EDT | Kerrii B AndersonDirector | 1,237 | — | — | 14,272 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:45 pm EDT | Lance BerberianSVP, Chief Information Officer | 533 | $115.49 | $15,360 | 2,205 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:44 pm EDT | Edward T DodsonPrincipal Accounting Officer | 524 | $115.49 | $14,321 | 7,773 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:42 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 2,404 | $115.49 | $89,851 | 7,596 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:41 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 617 | $115.49 | $17,785 | 18,375 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:39 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 4,369 | $115.49 | $163,187 | 24,997 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:37 pm EDT | David P KingPresident & CEO, Director | 8,981 | $115.49 | $335,498 | 94,489 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:36 pm EDT | Deborah L KellerCEO, Covance Drug Development | 17,517 | $115.49 | $529,753 | 19,754 | — | plan? |
| Mar 11, 2016 FMForm 4 → | Mar 15, 1:34 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 11,595 | $115.49 | $390,241 | 8,577 | — | plan? |
| Feb 25, 2016 SForm 4 → | Feb 29, 1:52 pm EST | Jean-Luc BelingardDirector | 1,296 | $109.74 | $142,225 | 29,426 | −4.22% | plan? |
| Feb 25, 2016 MForm 4 → | Feb 29, 1:52 pm EST | Jean-Luc BelingardDirector | 1,296 | $59.37 | $76,944 | 30,722 | — | plan? |
| Feb 16, 2016 SForm 4 → | Feb 18, 8:28 am EST | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 4,055 | $103.02 | $417,746 | 23,454 | −14.7% | plan? |
| Feb 16, 2016 SForm 4 → | Feb 18, 8:27 am EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 370 | $103.02 | $38,117 | 18,066 | −2.01% | plan? |
| Feb 12, 2016 SForm 4 → | Feb 16, 4:30 pm EST | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 2,712 | $101.67 | $275,729 | 23,454 | −10.4% | plan? |
| Feb 12, 2016 SForm 4 → | Feb 16, 4:21 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 405 | $101.67 | $41,176 | 18,066 | −2.19% | plan? |
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:30 pm EST | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 13,689 | $102.39 | $354,373 | 27,509 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2017 MForm 4 → | Aug 29, 2:26 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 31,500 | — | — | 0 | — | |
| Aug 11, 2017 MForm 4 → | Aug 15, 3:03 pm EDT | R Sanders WilliamsDirector | 3,100 | — | — | 0 | — | |
| Jun 16, 2017 MForm 4 → | Jun 19, 2:48 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 4,050 | — | — | 14,361 | — | |
| May 9, 2017 MForm 4 → | May 11, 8:17 am EDT | Jean-Luc BelingardDirector | 992 | — | — | 0 | — | |
| Apr 4, 2017 AForm 4 → | Apr 6, 9:55 am EDT | M. Huff GaryCEO, LabCorp Diagnostics | 12,390 | — | — | 14,190 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 3:17 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 8,217 | — | — | 2,724 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 2:52 pm EDT | Lance BerberianSVP, Chief Information Officer | 400 | — | — | 8,284 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 2:44 pm EDT | Edward T DodsonPrincipal Accounting Officer | 400 | — | — | 2,040 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 2:43 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 463 | — | — | 2,394 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 2:41 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 1,627 | — | — | 18,411 | — | |
| Mar 11, 2017 MForm 4 → | Mar 14, 2:39 pm EDT | David P KingPresident & CEO, Director | 6,077 | — | — | 33,824 | — | |
| Feb 24, 2017 MForm 4 → | Feb 27, 2:40 pm EST | Robert E Mittelstaedt Jr.Director | 5,300 | — | — | 0 | — | |
| Feb 23, 2017 MForm 4 → | Feb 27, 2:39 pm EST | Kerrii B AndersonDirector | 2,992 | — | — | 3,300 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:45 pm EST | Edward T DodsonPrincipal Accounting Officer | 550 | — | — | 2,440 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:45 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 634 | — | — | 2,857 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:42 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,674 | — | — | 20,038 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:42 pm EST | Lance BerberianSVP, Chief Information Officer | 1,480 | — | — | 8,684 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:42 pm EST | David P KingPresident & CEO, Director | 8,344 | — | — | 39,901 | — | |
| Feb 11, 2017 MForm 4 → | Feb 14, 5:40 pm EST | Lance BerberianSVP, Chief Information Officer | 1,480 | — | — | 8,684 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:40 pm EST | Lisa J UthgenanntChief Human Resources Officer | 603 | — | — | 10,941 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:31 pm EST | Edward T DodsonPrincipal Accounting Officer | 450 | — | — | 2,990 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:28 pm EST | John D RatliffCEO, Covance Drug Development | 6,100 | — | — | 17,790 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:26 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 520 | — | — | 3,491 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:24 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 4,876 | — | — | 21,712 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:23 pm EST | Lance BerberianSVP, Chief Information Officer | 3,496 | — | — | 10,164 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:21 pm EST | David P KingPresident & CEO, Director | 7,543 | — | — | 48,245 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:04 pm EST | Richelle P ParhamDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 2:01 pm EST | Adam H SchechterDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:58 pm EST | R Sanders WilliamsDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:55 pm EST | Peter M NeupertDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:53 pm EST | Jean-Luc BelingardDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:51 pm EST | Kerrii B AndersonDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:49 pm EST | Garheng KongDirector | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:46 pm EST | Robert E Mittelstaedt Jr.Director | 1,560 | — | — | 1,263 | — | |
| Feb 9, 2017 MForm 4 → | Feb 13, 1:43 pm EST | Dwight Gary GillilandDirector | 1,560 | — | — | 1,263 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:45 pm EST | Lisa J UthgenanntChief Human Resources Officer | 4,680 | — | — | 3,700 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:44 pm EST | John D RatliffCEO, Covance Drug Development | 26,890 | — | — | 21,300 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:43 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 14,380 | — | — | 11,400 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:42 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 4,290 | — | — | 3,400 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:41 pm EST | Edward T DodsonPrincipal Accounting Officer | 3,540 | — | — | 2,800 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:40 pm EST | Lance BerberianSVP, Chief Information Officer | 4,290 | — | — | 3,400 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:39 pm EST | David P KingPresident & CEO, Director | 60,960 | — | — | 48,300 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:29 pm EST | Kerrii B AndersonDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:28 pm EST | Jean-Luc BelingardDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:26 pm EST | Dwight Gary GillilandDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:25 pm EST | Garheng KongDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:24 pm EST | Robert E Mittelstaedt Jr.Director | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:23 pm EST | Peter M NeupertDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:22 pm EST | Richelle P ParhamDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:20 pm EST | Adam H SchechterDirector | 1,263 | — | — | 2,823 | — | |
| Feb 7, 2017 AForm 4 → | Feb 9, 2:15 pm EST | R Sanders WilliamsDirector | 1,263 | — | — | 2,823 | — | |
| Oct 3, 2016 AForm 4 → | Oct 5, 3:57 pm EDT | John D RatliffCEO, Covance Drug Development | 18,300 | — | — | 18,300 | — | |
| Aug 4, 2016 MForm 4 → | Aug 8, 2:55 pm EDT | Robert E Mittelstaedt Jr.Director | 992 | — | — | 0 | — | |
| Jun 16, 2016 MForm 4 → | Jun 20, 10:38 am EDT | Glenn A EisenbergChief Financial Officer, EVP | 4,050 | — | — | 23,608 | — | |
| Jun 13, 2016 MForm 4 → | Jun 15, 4:03 pm EDT | David P KingPresident & CEO, Director | 196,400 | — | — | 0 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:40 pm EDT | Robert E Mittelstaedt Jr.Director | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:39 pm EDT | Peter M NeupertDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:39 pm EDT | Garheng KongDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:38 pm EDT | Adam H SchechterDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:37 pm EDT | Dwight Gary GillilandDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:37 pm EDT | R Sanders WilliamsDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:35 pm EDT | Jean-Luc BelingardDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 3:35 pm EDT | Kerrii B AndersonDirector | 1,237 | — | — | 1,560 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:45 pm EDT | Lance BerberianSVP, Chief Information Officer | 400 | — | — | 12,770 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:44 pm EDT | Edward T DodsonPrincipal Accounting Officer | 400 | — | — | 2,700 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:42 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 1,626 | — | — | 27,658 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:41 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 463 | — | — | 3,121 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:39 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 2,956 | — | — | 11,631 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:37 pm EDT | David P KingPresident & CEO, Director | 6,076 | — | — | 43,128 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:36 pm EDT | Deborah L KellerCEO, Covance Drug Development | 12,930 | — | — | 18,270 | — | |
| Mar 11, 2016 MForm 4 → | Mar 15, 1:34 pm EDT | Lisa J UthgenanntChief Human Resources Officer | 8,216 | — | — | 10,564 | — | |
| Feb 25, 2016 MForm 4 → | Feb 29, 1:52 pm EST | Jean-Luc BelingardDirector | 1,296 | — | — | 0 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:30 pm EST | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 10,228 | — | — | 14,587 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:25 pm EST | David P KingPresident & CEO, Director | 16,613 | — | — | 49,204 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:24 pm EST | Edward T DodsonPrincipal Accounting Officer | 1,097 | — | — | 3,100 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:23 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 3,213 | — | — | 29,284 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:22 pm EST | Lance BerberianSVP, Chief Information Officer | 1,480 | — | — | 13,170 | — | |
| Feb 11, 2016 MForm 4 → | Feb 16, 4:21 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,180 | — | — | 3,584 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:42 pm EST | Deborah L KellerCEO, Covance Drug Development | 4,120 | — | — | 31,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:39 pm EST | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 1,660 | — | — | 24,815 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:35 pm EST | Lisa J UthgenanntChief Human Resources Officer | 1,810 | — | — | 18,780 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:34 pm EST | Edward T DodsonPrincipal Accounting Officer | 1,350 | — | — | 4,197 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:33 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 14,630 | — | — | 32,497 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:32 pm EST | Lance BerberianSVP, Chief Information Officer | 10,490 | — | — | 14,650 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:31 pm EST | David P KingPresident & CEO, Director | 22,630 | — | — | 65,817 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:29 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,560 | — | — | 4,764 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | R Sanders WilliamsDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Peter M NeupertDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Adam H SchechterDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Dwight Gary GillilandDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Garheng KongDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:23 pm EST | Robert E Mittelstaedt Jr.Director | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:15 pm EST | Jean-Luc BelingardDirector | 1,560 | — | — | 2,797 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:08 pm EST | Richelle P ParhamDirector | 1,560 | — | — | 1,560 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:07 pm EST | Kerrii B AndersonDirector | 1,560 | — | — | 2,797 | — | |
| Nov 2, 2015 MForm 4 → | Nov 4, 3:20 pm EST | R Sanders WilliamsDirector | 1,850 | — | — | 0 | — | |
| Oct 29, 2015 MForm 4 → | Nov 2, 2:31 pm EST | Kerrii B AndersonDirector | 1,296 | — | — | 0 | — | |
| Aug 3, 2015 MForm 4 → | Aug 5, 3:53 pm EDT | David P KingPresident & CEO, Director | 50,000 | — | — | 0 | — | |
| Jul 31, 2015 MForm 4 → | Aug 4, 2:15 pm EDT | Joseph L HerringCEO of Covance Drug Division | 19,990 | — | — | 0 | — | |
| Jul 1, 2015 MForm 4 → | Jul 6, 9:08 pm EDT | David P KingPresident & CEO, Director | 50,000 | — | — | 50,000 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2016 PForm 4 → | Sep 7, 5:22 pm EDT | SEQUENOM INCSQNM | 36,649,440 | $2.40 | $87,958,656 | 119,551,297 | +44.2% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.